Elahi Shan, Tasneem Affia, Nazir Irfana, Nagra Saeed Ahmed, Hyder Syed Waqar
Centre for Nuclear Medicine (CENUM), Mayo Hospital, Lahore.
J Coll Physicians Surg Pak. 2007 Apr;17(4):191-4.
To determine the frequency of thyroid dysfunction in infertile women referred for thyroid evaluation.
A retrospective case-control study.
This study was carried out at Centre for Nuclear Medicine (CENUM), Mayo Hospital, Lahore, from July 2003 to December 2006.
Age matched infertile (n=140 each) and fertile women (n=152 each) referred to CENUM for thyroid evaluation were investigated for incidence of hyperthyroidism (TSH < 0.03 mIU/L), hypothyroidism (TSH < 0.03 mIU/L) and thyroid autoimmunity (antithyroid peroxidase antibody titer>20 IU/L). Serum free T4 (FT4), free T3 (FT3) and antithyroid peroxidase antibody (TPO-Ab) was determined by radioimmunoassay (RIA) and TSH by immunoradiometric assay (IRMA).
Most of the infertile women (89.3%), like control women (93.4%), were euthyroid. The difference of overall thyroid dysfunction was not statistically significant in infertile and control women (10.7% vs. 7.9%; p=0.395). The same was true for incidence of hyperthyroidism (4.3% vs. 5.3%; p=0.701) as well as hypothyroidism (6.4% vs. 2.6%; p=0.104). In infertile women, the incidence of hypothyroidism (6.4%) was slightly higher as compared to hyperthyroidism (4.3%). In euthyroid women of both groups, mean FT4, FT3 and TSH levels were significantly higher (p < 0.05) in infertile women and double number of them had serum TSH>2.5 mIU/L compared to fertile women (31.2% vs. 15.6%; p<0.01). Similarly, more infertile women were TPO-Ab positive (titer>20 IU/L) than control women (7.2% vs. 1.4%; p < 0.05).
Increased incidence of high normal TSH and raised TPO-Ab titer indicate relatively more frequent occurrence of compensated thyroid function in infertile women than normal women of reproductive age. This necessitates considering them a subgroup of women in which all aspects of pituitary-thyroid axis should be thoroughly investigated than merely TSH testing.
确定因甲状腺评估而转诊的不孕女性甲状腺功能障碍的发生率。
一项回顾性病例对照研究。
本研究于2003年7月至2006年12月在拉合尔梅奥医院核医学中心(CENUM)开展。
将年龄匹配的不孕女性(各140例)和生育期女性(各152例)转诊至CENUM进行甲状腺评估,调查甲状腺功能亢进(促甲状腺激素[TSH]<0.03 mIU/L)、甲状腺功能减退(TSH>4.5 mIU/L)及甲状腺自身免疫(抗甲状腺过氧化物酶抗体滴度>20 IU/L)的发生率。采用放射免疫分析法(RIA)测定血清游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)及抗甲状腺过氧化物酶抗体(TPO-Ab),采用免疫放射分析法(IRMA)测定TSH。
大多数不孕女性(89.3%)与对照女性(93.4%)一样,甲状腺功能正常。不孕女性与对照女性总体甲状腺功能障碍的差异无统计学意义(10.7%对7.9%;p=0.395)。甲状腺功能亢进(4.3%对5.3%;p=0.701)及甲状腺功能减退(6.4%对2.6%;p=0.104)的发生率情况相同。在不孕女性中,甲状腺功能减退的发生率(6.4%)略高于甲状腺功能亢进(4.3%)。在两组甲状腺功能正常的女性中,不孕女性的平均FT4、FT3及TSH水平显著更高(p<0.05),且血清TSH>2.5 mIU/L的不孕女性数量是生育期女性的两倍(31.2%对15.6%;p<0.01)。同样,不孕女性中TPO-Ab阳性(滴度>20 IU/L)的人数多于对照女性(7.2%对1.4%;p<0.05)。
高正常TSH及TPO-Ab滴度升高的发生率增加表明,与育龄正常女性相比,不孕女性中代偿性甲状腺功能更常见。这就需要将她们视为一个女性亚组,其中应全面调查垂体-甲状腺轴的各个方面,而不仅仅是检测TSH。